Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial

…, UN Siddiqui, I Farooq, R Akmal… - Phytotherapy …, 2023 - Wiley Online Library
Until now, no specific and effective treatment exists for coronavirus disease 2019 (COVID‐19).
Since honey and Nigella sativa (HNS) have established antiviral, antibacterial, …

[HTML][HTML] Knowledge, attitude, and practice of clinicians about antimicrobial stewardship and resistance among hospitals of Pakistan: a multicenter cross-sectional …

…, M Ghufran, SSH Sherazi, MK Akram, R Akmal… - … Science and Pollution …, 2022 - Springer
Considering that antimicrobial resistance (AMR) is a global challenge, there is a dire need to
assess the knowledge, attitude, and practice (KAP) of clinicians in AMR endemic countries. …

Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a …

S Ashraf, S Ashraf, R Akmal, M Ashraf, L Kalsoom… - Trials, 2021 - Springer
Objectives Considering the therapeutic potential of honey and Nigella sativa (HNS) in
coronavirus disease 2019 (COVID-19) patients, the objective of the study is defined to evaluate …

ROLE OF ALPRAZOLAM AS A HEART RATE LOWERING AGENT IN ANXIOUS PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME (A-ACS-PK TRIAL)

S Ashraf, R Akmal, A Mustaqeem, M Ashraf… - Journal of the American …, 2023 - jacc.org
Background Acute coronary syndrome (ACS) is a pathological condition defined by acute
coronary artery obstruction. The key target in its management is oxygen demand which is …

[HTML][HTML] Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial

…, A Hilal, A Khaqan, MK Akram, S Ashraf, R Akmal… - medRxiv, 2020 - medrxiv.org
BACKGROUND No definitive treatment exists for Coronavirus Disease 2019 (COVID-19).
Honey and Nigella sativa (HNS) has established anti-viral properties. Hence, we investigated …

[HTML][HTML] Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study …

…, S Ashraf, M Ashraf, MA Imran, L Kalsoom, R Akmal… - Trials, 2021 - Springer
Objectives The study objective is to quantify the effectiveness of ivermectin (subcutaneous/oral
IVM) in the presence or absence of zinc (Zn) for clinical and radiological improvement in …

[HTML][HTML] Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial

S Ashraf, S Ashraf, M Ashraf, I Farooq, R Akmal… - Trials, 2022 - Springer
Background Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus-infected
millions globally. Despite a wide range of advised options for the treatment of COVID-19, a …

[HTML][HTML] A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an iodine complex for patients with mild to moderate COVID-19 in …

…, MK Akram, I Shahid, M Sohaib Ur Rehman, R Akmal… - Trials, 2021 - Springer
Objectives The objective of the study is to measure the efficacy of ionic-iodine polymer
complex [ 1 ] for clinical and radiological improvement in coronavirus disease 2019 (COVID-19) …

Factors Responsible for Worse Outcomes in STEMI Patients With Early vs Delayed Treatment Presenting in a Tertiary Care Center in a Third World Country

…, A Shahbaz, F Khalique, M Ashraf, R Akmal… - Current Problems in …, 2023 - Elsevier
Introduction The aim of the study is to compare the outcomes among STEMI cases with
early treatment vs delayed treatment. Method It was a prospective comparative study on 186 …

[PDF][PDF] Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial

J First, J Second - happycultureinc.com
METHODS: We conducted a multicenter, placebo-controlled, randomized clinical trial at 4
centers in Pakistan. RT-PCR confirmed COVID-19 adults showing moderate or severe disease …